Status:
UNKNOWN
Screening for Metabolic Dysfunction Associated Fatty Liver Disease (MAFLD) at Al-Rajhy Hospital Nutrition Clinic. Assiut, Egypt
Lead Sponsor:
Assiut University
Conditions:
Steatohepatitis, Nonalcoholic
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Primary outcome Screen for MAFLD among patients attending to the Nutrition clinic in Al Rajhi hospital. Secondary outcome * Determining the degrees of fibrosis and steatosis in patients with MAFLD *...
Detailed Description
Metabolic dysfunction-associated fatty liver disease (MAFLD) formly called non alcoholic fatty liver disease (NAFLD) was defined as the presence of macrovesicular steatosis in ≥5% of hepatocytes in in...
Eligibility Criteria
Inclusion
- Age: 18-80 years
Exclusion
- Pregnant females.
- Patients who will refuse to participate in the study.
Key Trial Info
Start Date :
September 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2022
Estimated Enrollment :
360 Patients enrolled
Trial Details
Trial ID
NCT04861012
Start Date
September 1 2021
End Date
December 1 2022
Last Update
April 27 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.